# Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study

> **NCT07347379** · — · ENROLLING_BY_INVITATION · sponsor: **RxSight, Inc.** · enrollment: 500 (estimated)

## Conditions studied

- Aphakia Cataract

## Interventions

- **DEVICE:** Light Adjustable lens (LAL) and Light Delivery Device (LDD)
- **DEVICE:** Control IOL

## Key facts

- **NCT ID:** NCT07347379
- **Lead sponsor:** RxSight, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-11-13
- **Primary completion:** 2026-06
- **Final completion:** 2026-09
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07347379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07347379, "Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07347379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*